Continuous biosensing goes beyond glucose for better personal monitoring
The composition of blood is typically evaluated with blood tests, to reveal abnormalities associated with diseases or metabolism as well as changes related to ageing or menopause. For some time, diabetics have benefitted from continuous glucose monitoring (CGM) via a tiny sensor under the skin that reports glucose levels in real time. CGM has minimised the need for repetitive blood tests while enhancing the temporal resolution of changes, altering the course of the disease for many. The EU-funded CONSENSE project is now developing new sensor technologies suited for measuring a wealth of other biomolecules that are critical to health status, for truly personalised medicine and better outcomes.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeMSCA-ITN-ETN - European Training Networks
5612 AZ Eindhoven